Save on Kisunla with Coupons, Discounts & Savings Programs

Kisunla (donanemab-azbt) is an amyloid beta-directed antibody indicated for the treatment of Alzheimer ‘s disease.

Kisunla is available as a 350 mg/20 mL once-monthly injection for IV infusion.

Kisunla is an IV infusion used to treat Alzheimer’s disease.

Kisunla is targets beta-amyloid, a toxic protein that builds up in the brains of people with Alzheimer’s and forms plaques that can disrupt brain signaling. Kisunla helps clear these plaques, which can help improve memory and thinking.

The recommended dosage of Kisunla is 700 mg given as an IV infusion over 30 minutes every four weeks for the first three doses, followed by 1400 mg every four weeks. Your dose may be adjusted based on how well it works to remove plaque build-up.

Kisunla is a safe and effective treatment when used for FDA approved indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you. You should not take Kinsula if you are allergic to donanemab-azbt or to any of the inactive ingredients in the product.

Common side effects of Kisunla: Headache

Serious side effects are rare with Kisunla. Contact your healthcare provider immediately if you experience any of the following: Allergic reactions or angioedema: skin rash, itching or hives, swelling of the face, eyes, lips, tongue, arms, or legs, trouble swallowing or breathing Worsening confusion, dizziness, change in vision, nausea, seizures Infusion reactions: chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded

There are no drug interactions listed for Kisunla.

Eli Lilly and Company

It is not known whether Kisunla will harm your unborn baby. Talk with your healthcare provider about the risks of taking this medication if you are pregnant or plan on becoming pregnant.

• Donanemab-AZBT